Cronos (CRON) Short term Debt (2021 - 2023)
Cronos' (CRON) quarterly Short term Debt came in at $375000.0 in Q1 2023, down 2.34% quarter-over-quarter from $384000.0 in Q4 2022.
Cronos (CRON) Short term Debt (2021 - 2023) Analysis & Trends
Cronos' Short term Debt history runs 3 years deep, the most recent figure standing at $375000.0 for Q1 2023.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $375000.0 in Q1 2023; TTM through Mar 2023 was $375000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $384000.0, down 11.32% from the prior year.
- Short term Debt fell to $375000.0 in Q1 2023 per CRON's latest filing, from $384000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $433000.0 in Q4 2021 and bottomed at $375000.0 in Q1 2023.
- The 3-year median for Short term Debt is $381500.0 (2022), against an average of $392750.0.
- Biggest YoY gain for Short term Debt was 11.32% in 2022; the steepest drop was 11.32% in 2022.
- Year by year, Short term Debt stood at $433000.0 in 2021, then dropped by 11.32% to $384000.0 in 2022, then slipped by 2.34% to $375000.0 in 2023.
- Per Business Quant, the three latest CRON Short term Debt figures stand at $375000.0 (Q1 2023), $384000.0 (Q4 2022), and $379000.0 (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 375,000.00 |
| Dec 31, 2022 | 384,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Dec 31, 2021 | 433,000.00 |